{
  "object_id": "SC:v1.0.0-database-resource:EHMT2:1.5-DRAFT",
  "card_schema": "nmd-vcell-study-card/1.5",
  "card_version": "1.5",
  "resource_release": "v1.0.0-database-resource",
  "evidence_freeze": "2026-07-25",
  "interface_build": "EA-20260729-15",
  "gene": "EHMT2",
  "card_type": "computational_replication",
  "current_action_code": "computational_replication",
  "current_action": "Computational replication",
  "lifecycle": {
    "state": "DRAFT",
    "revision": 1,
    "immutable": false,
    "registered_at": null,
    "supersedes": null,
    "immutable_after_registration": true
  },
  "decision_blocking_gap": {
    "code": "GAP-07",
    "label": "Independent computational replication is absent"
  },
  "highest_missing_evidence_layer": "L4_dmd_functional_validation",
  "secondary_gaps": [
    "GAP-02 independent muscle-context perturbation",
    "GAP-03 DMD-relevant functional validation"
  ],
  "frozen_evidence_snapshot": {
    "snapshot_schema": "nmd-vcell-study-card-frozen-evidence-snapshot/1.0",
    "source_record": "gene/EHMT2",
    "highest_supported_level": "L2_observed_same_context_perturbation",
    "highest_assessed_level": "L2_observed_same_context_perturbation",
    "observed_hepg2_perturbation": {
      "assessment_status": "assessed",
      "support_status": "supported",
      "observed_cells": 101
    },
    "external_context_screen": {
      "assessment_status": "not_assessed",
      "support_status": null,
      "hit": null,
      "effect_size": null,
      "fdr": null,
      "interpretation": null
    },
    "dmd_prior": {
      "integrated_prior_direction": "up",
      "source_direction_state": "conflicted",
      "source_agreement_proportion": 0.75,
      "agreeing_sources": 3,
      "assessed_sources": 4,
      "coverage_state": "4_of_4_sources",
      "uncertainty_state": "direction_conflict_retained"
    },
    "context_metrics": {
      "skeletal_muscle_median_tpm": 6.40587,
      "depmap_median_gene_effect": -0.2218054354039832,
      "moderate_dependency_flag": false
    },
    "visual_boundary": "Descriptive frozen evidence snapshot only; no score, rank, cluster, prediction claim or intervention recommendation is generated."
  },
  "unresolved_question": "Does the EHMT2 evidence pattern replicate in an independent dataset under a frozen analysis plan?",
  "biological_context": "At least one independent dataset with declared tissue/cell state, disease status and gene-mapping coverage.",
  "perturbation_modality": "No new wet-lab perturbation is nominated; rerun the frozen direction, pathway and robustness analyses.",
  "comparator_and_controls": [
    "Frozen null and simple baselines.",
    "Leave-one-source-out analysis.",
    "Negative-control genes or permuted labels.",
    "Complete unmatched-identifier report."
  ],
  "primary_endpoint": "Predeclared gene-level direction or effect estimate in the independent dataset.",
  "secondary_endpoints": [
    "Pathway concordance.",
    "Leave-one-source-out robustness.",
    "Coverage and null-result diagnostics."
  ],
  "primary_estimand": "Independent-dataset gene effect and uncertainty under the frozen contrast.",
  "state_transition_design": {
    "scientific_object": "perturbation × cell state × disease context × time × phenotype",
    "mechanism_hypothesis": "Required before registration: state the proposed early molecular mediator, the expected cell-state transition and the downstream functional consequence.",
    "cell_context_fields": {
      "disease_background": "Required before registration: healthy, DMD or isogenic corrected.",
      "myogenic_state": "Required before registration: proliferating myoblast, early differentiation, fusion or maturing myotube.",
      "donor_or_isogenic_pair": "Required before registration; preserve donor-specific estimates."
    },
    "timepoint_plan": [
      {
        "window": "6–12 h",
        "role": "early molecular or signalling response",
        "status": "planning_default_requires_assay_calibration"
      },
      {
        "window": "24–48 h",
        "role": "regulatory program and cell-state transition",
        "status": "planning_default_requires_assay_calibration"
      },
      {
        "window": "4–7 d",
        "role": "differentiation and functional phenotype",
        "status": "planning_default_requires_assay_calibration"
      }
    ],
    "endpoint_domains": {
      "target_engagement": [
        "mRNA",
        "protein where validated",
        "perturbation efficiency"
      ],
      "functional": [
        "fusion",
        "morphology",
        "membrane integrity",
        "calcium",
        "contraction"
      ],
      "safety": [
        "viability",
        "proliferation",
        "differentiation blockade",
        "global stress"
      ],
      "replication": [
        "reagent",
        "donor or isogenic pair",
        "future batch"
      ]
    },
    "cell_cell_consequence": {
      "current_status": "not_assessed",
      "future_levels": [
        "conditioned medium",
        "two-cell co-culture",
        "three-dimensional muscle model",
        "spatial perturbation model"
      ]
    },
    "response_archetype": {
      "current_status": "not_assessed",
      "allowed_values": [
        "robust_responder",
        "dmd_specific_responder",
        "donor_variable",
        "state_specific",
        "toxic_responder",
        "null_with_equivalence_margin",
        "discordant",
        "qc_failure",
        "inconclusive"
      ]
    }
  },
  "perturbation_direction_rationale": {
    "selected_hypothesis": "unresolved_requires_registration",
    "allowed_hypotheses": [
      "activation",
      "inhibition",
      "bidirectional_exploration",
      "direction_not_identifiable"
    ],
    "required_justification": "State whether the disease-associated direction is hypothesized as causal, compensatory or accompanying, and preserve the opposite-direction alternative. DMD direction and counteralignment never choose an intervention automatically."
  },
  "minimally_important_effect": "Required before registration; derive from assay biology or a justified pilot and store the numeric value with units.",
  "negligible_effect_margin": "Required before interpreting a null result; store a symmetric or asymmetric numeric margin with units.",
  "suggested_sample_size_range": "One or more independent datasets; donor/sample adequacy must be justified from the source design rather than a generic target count.",
  "randomisation_unit": "Independent donor/sample/study unit defined by the source dataset.",
  "blocking_factors": [
    "Study/donor.",
    "Batch.",
    "Cell state.",
    "Dataset-specific covariates."
  ],
  "statistical_model": "Dataset-appropriate pseudobulk or aggregate model with donor/sample as the inferential unit.",
  "multiple_testing_family": "Frozen gene and pathway families with declared adjustment method.",
  "missing_data_rule": "Define exclusions before unblinding; report all missing units and reasons; do not single-impute primary outcomes without a prespecified sensitivity analysis.",
  "assay_qc_thresholds": [
    "Minimum donor/sample coverage.",
    "Gene detectability.",
    "Frozen mapping and exclusion thresholds."
  ],
  "guide_concordance_rule": "Not applicable unless the independent dataset contains multiple perturbation reagents.",
  "donor_replication_rule": "A result must persist beyond a single donor/sample and disclose leave-one-unit-out sensitivity.",
  "estimated_time_band": "1–4 weeks after data access; planning estimate only.",
  "estimated_cost_band": "Institution- and assay-dependent; obtain a local itemised quote before registration.",
  "preregistration_status": "draft_requires_direction_rationale_numeric_effect_margin_sample_size_and_qc_thresholds",
  "inferential_unit": "Independent biological replicate or independently generated perturbation unit; cells within one aggregate are not inferential replicates.",
  "evidence_import_requirements": [],
  "planning_fields_not_applicable": [],
  "stop_rules": [
    "Stop or classify as infeasible if a required numeric QC threshold fails.",
    "Do not interpret a nonsignificant result as no material effect without a negligible-effect interval.",
    "Do not change canonical candidate status automatically; require governed review."
  ],
  "escalation_rule": "Escalate from L2 to L3b only after independent context-matched perturbation replication; L4 requires replicated DMD-relevant muscle evidence.",
  "evidence_transition": "Current evidence state → predeclared independent test → governed evidence-level review.",
  "data_release_plan": "Release the frozen card, protocol identifiers, analysis code, complete denominators and results irrespective of direction; never overwrite the registered card.",
  "boundary": "This Study Card is an evidence-gated design scaffold, not a protocol, power calculation, safety claim, prediction or therapeutic recommendation.",
  "stable_url": "study-card/EHMT2",
  "exports": {
    "json": "api/v1.1/study-cards/EHMT2.json",
    "yaml": "downloads/study-cards/EHMT2.yaml",
    "tsv": "downloads/study-cards/EHMT2.tsv"
  }
}
